4.7 Article

Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus

Journal

RHEUMATOLOGY
Volume 55, Issue 5, Pages 869-873

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kev436

Keywords

systemic lupus erythematosus; juvenile SLE; Complement system; pediatric rheumatology; immunogenetics; gene copy number

Categories

Funding

  1. FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo) [08/57316-1, 08/58238-4]

Ask authors/readers for more resources

Objective. Complete deficiency of Complement C4 component is a strong genetic risk factor for SLE. C4 is encoded by two different genes, C4A and C4B, which show considerable gene copy number (GCN) variation. This study investigates the association of total C4, C4A and C4B GCN with JSLE. Methods. Ninety JSLE patients, 170 adult-onset SLE (aSLE) patients and 200 healthy individuals were evaluated for C4A and C4B GCN by quantitative real-time PCR. Results. JSLE patients had lower GCN for C4A (mean = 1.7; 95% CI: 1.5, 1.9) and C4B (mean = 1.5; 95% CI: 1.3, 1.6) compared with healthy individuals (mean C4A = 2.3; 95% CI: 2.2, 2.5, P< 0.001; C4B = 2.0; 95% CI: 1.8, 2.1; P< 0.001) or with aSLE patients (mean C4A = 1.9; 95% CI: 1.8, 2.1, P = 0.006; mean C4B = 1.8; 95% CI: 1.7, 1.9, P< 0.001). Low total C4 GCN (< 4 copies) was more frequent in JSLE than in healthy individuals (59% vs 28%; P< 0.001). The same was observed for low C4A (<= 1 copy) (52% vs 18%; P< 0.001) and for low C4B (60% vs 31%; P< 0.001). JSLE had a stronger association with low total C4 (OR = 3.68, 95% CI: 2.19, 6.20), C4A (OR = 4.98, 95% CI: 2.88, 8.62) and C4B (OR = 3.26; 95% CI: 1.95, 5.47) than aSLE (C4 OR= 2.03; 95% CI: 1.32, 3.13; C4A OR= 2.36; 95% CI: 1.46, 3.81; C4B OR= 1.13; 95% CI: 0.73, 1.74). In addition, pericarditis in JSLE patients was associated with low C4 (OR= 4.13; 95% CI: 1.02, 16.68; P = 0.047) and low C4A (OR = 5.54; 95% CI: 1.37, 22.32; P = 0.016). Conclusion. Low total C4, C4A and C4B GCN were associated with a stronger risk for developing JSLE than aSLE. Additionally, low total C4 and C4A GCN are risk factors for pericarditis in JSLE.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Medicine, General & Internal

Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine

Telma Miyuki Oshiro, Lais Teodoro da Silva, Marina Mazzilli Ortega, Sandro Felix Perazzio, Alberto Jose da Silva Duarte, Magda Carneiro-Sampaio

CLINICS (2022)

Review Pediatrics

Inborn Errors of Immunity With Fetal or Perinatal Clinical Manifestations

Magda Carneiro-Sampaio, Adriana Almeida de Jesus, Silvia Yumi Bando, Carlos Alberto Moreira-Filho

Summary: This article reviews the literature on Inborn Errors of Immunity (IEI), focusing on diseases with intrauterine or perinatal manifestations. The main finding is that these early manifestations are mainly concentrated in the group of primary immune regulatory disorders and autoinflammatory diseases.

FRONTIERS IN PEDIATRICS (2022)

Correction Medical Laboratory Technology

The International Consensus on ANA Patterns (ICAP) in 2021-the 6th Workshop and Current Perspectives (vol 7, pg 322, 2022)

Edward K. L. Chan, Carlos A. von Muhlen, Marvin J. Fritzler, Jan Damoiseaux, Maria Infantino, Werner Klotz, Minoru Satoh, Lucile Musset, Ignacio Garcia-De La Torre, Orlando Gabriel Carballo, Manfred Herold, Wilson de Melo Cruvinel, Tsuneyo Mimori, Karsten Conrad, Luis E. C. Andrade

JOURNAL OF APPLIED LABORATORY MEDICINE (2023)

Article Multidisciplinary Sciences

Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19

Marina Mazzilli Ortega, Lais Teodoro da Silva, Erika Donizetti Candido, Yingying Zheng, Bruna Tiaki Tiyo, Arthur Eduardo Fernandes Ferreira, Simone Correa-Silva, Guilherme Pereira Scagion, Fabyano Bruno Leal, Vanessa Nascimento Chalup, Camila Araujo Valerio, Gabriela Justamante Handel Schmitz, Carina Ceneviva, Aline Pivetta Cora, Alexandre de Almeida, Edison Luiz Durigon, Danielle Bruna Leal Oliveira, Patricia Palmeira, Alberto Jose da Silva Duarte, Magda Carneiro-Sampaio, Telma Miyuki Oshiro

Summary: We investigated the immune response to the SARS-CoV-2 vaccine (CoronaVac) in healthcare workers who had received two doses of the inactivated virus-based vaccine. Our study analyzed serum and salivary antibodies, serum antibody neutralizing activity, and cellular immune response. The results showed that CoronaVac induced the production of specific serum and saliva antibodies, as well as IFN-gamma producing T cells, in most individuals who had recovered from COVID-19 and/or were vaccinated. The vaccine demonstrated neutralizing activity against the ancestral strain, but a reduced response against the variants. Vaccinated individuals with previous COVID-19 infection exhibited higher immune responses compared to those without previous infection.

SCIENTIFIC REPORTS (2022)

Article Pediatrics

Expanding the Phenotype of 8p23.1 Deletion Syndrome: Eight New Cases Resembling the Clinical Spectrum of 22q11.2 Microdeletion

Marilia Moreira Montenegro, Debora Camilotti, Caio Robledo D'Anglioli Costa Quaio, Yanca Gasparini, Evelin Aline Zanardo, Andreia Rangel-Santos, Gil Monteiro Novo-Filho, Gleyson Francisco, Lucas Liro, Amom Nascimento, Samar Nasser Chehimi, Diogo Cordeiro Queiroz Soares, Ana C. V. Krepischi, Marcilia Sierro Grassi, Rachel Sayuri Honjo, Patricia Palmeira, Chong Ae Kim, Magda Maria Sales Carneiro-Sampaio, Carla Rosenberg, Leslie Domenici Kulikowski

Summary: Early molecular diagnosis is effective in the clinical management of rare diseases. This study confirmed the presence of 8p23.1 deletion syndrome in 8 patients using molecular diagnosis. Cytogenomic screening is helpful for differential diagnosis and early detection of microdeletion syndromes.

JOURNAL OF PEDIATRICS (2023)

Article Multidisciplinary Sciences

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients

Clovis A. Silva, Ana C. Medeiros-Ribeiro, Leonard V. K. Kupa, Emily F. N. Yuki, Sandra G. Pasoto, Carla G. S. Saad, Solange R. G. Fusco, Rosa M. R. Pereira, Samuel K. Shinjo, Ari S. R. Halpern, Eduardo F. Borba, Fernando H. C. Souza, Lissiane K. N. Guedes, Renata Miossi, Karina R. Bonfiglioli, Diogo S. Domiciano, Andrea Y. Shimabuco, Danieli C. O. Andrade, Luciana P. C. Seguro, Ricardo Fuller, Percival D. Sampaio-Barros, Ana P. L. Assad, Julio C. B. Moraes, Claudia Goldenstein-Schainberg, Henrique A. M. Giardini, Henrique C. Silva, Victor A. O. Martins, Lorena E. B. Villamarin, Renata S. Novellino, Lucas P. Sales, Carlo S. R. Araujo, Matheus S. R. Silva, Dilson M. N. Filho, Marta H. Lopes, Alberto J. S. Duarte, Esper G. Kallas, Nadia E. Aikawa, Eloisa Bonfa

Summary: In autoimmune rheumatic disease patients, a phase 4 clinical trial showed a marked reduction in antibodies 6 months after the second dose of Sinovac-CoronaVac vaccine, especially in males or those under immune targeting therapies. However, there was no increase in COVID-19 cases.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C)

Guilherme S. Goncalves, Simone Correa-Silva, Yingying Zheng, Isabela Avelar, Marilia M. Montenegro, Arthur E. F. Ferreira, Vera Bain, Thais T. Fink, Priscila Suguita, Camilla Astley, Livia Lindoso, Fernanda Martins, Olivia M. Matsuo, Juliana C. O. A. Ferreira, Isabela Firigato, Fernanda de Toledo Goncalves, Maria Fernanda B. Pereira, Clovis Artur A. da Silva, Magda Carneiro-Sampaio, Heloisa H. S. Marques, Patricia Palmeira

Summary: The exacerbation of the inflammatory response caused by SARS-CoV-2 in adults promotes the production of soluble mediators that could act as diagnostic and prognostic biomarkers for COVID-19. Among these potential biomarkers, sTREM-1 has been identified as a predictor of inflammation severity. This study evaluated the concentrations of sTREM-1 and cytokines in pediatric patients with COVID-19 and found that sTREM-1 levels were higher in MIS-C patients, making it a potential early screening tool for MIS-C cases.

CYTOKINE (2023)

Article Rheumatology

Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis

Carla G. S. Saad, Matheus S. R. Silva, Percival D. Sampaio-Barros, Julio C. B. Moraes, Claudia G. Schainberg, Celio R. Goncalves, Andrea Y. Shimabuco, Nadia E. Aikawa, Emily F. N. Yuki, Sandra G. Pasoto, Leonard V. K. Kupa, Renato K. Aoyama, Carlo S. R. Araujo, Clovis A. Silva, Ana C. Medeiros-Ribeiro, Eloisa Bonfa

Summary: This study evaluated the humoral responses to the SARS-CoV-2 vaccine in patients with spondyloarthritis and found that therapy had an impact on the immune response. TNF inhibitors attenuated the immune response, while sulfasalazine had a positive impact on vaccine antibody production.

JOINT BONE SPINE (2023)

Editorial Material Medicine, General & Internal

The double-edged sword: COVID-19 pandemic-related delay in immune maturation in young children

Braian Lucas Aguiar, Magda Maria Sales Carneiro-Sampaio

CLINICS (2023)

Article Public, Environmental & Occupational Health

Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases

Bruno Gualano, Sofia M. Sieczkowska, Italo Ribeiro Lemes, Rafael Pires da Silva, Ana J. Pinto, Bruna C. Mazzolani, Fabiana I. Smaira, Nadia E. Aikawa, Leonard V. K. Kupa, Sandra G. Pasoto, Ana C. Medeiros-Ribeiro, Carla G. S. Saad, Emily F. N. Yuk, Clovis A. Silva, Paul Swinton, Pedro C. Hallal, Hamilton Roschel, Eloisa Bonfa

Summary: Physical activity is associated with improved immunogenicity after vaccination in patients with autoimmune rheumatic diseases (ARD). A study found that physically active patients had higher odds of better antibody responses to CoronaVac booster dose compared to inactive patients. These results support the recommendation of physical activity to enhance vaccination responses in immunocompromised individuals.

JOURNAL OF PHYSICAL ACTIVITY & HEALTH (2023)

Article Medicine, General & Internal

Major discrepancy between clinical diagnosis of death and anatomopathological findings in adolescents with chronic diseases during 18-years

Maira P. Ribeiro, Amaro N. Duarte-Neto, Marisa Dolhnikoff, Livia Lindoso, Benito Lourenco, Heloisa H. Marques, Maria F. B. Pereira, Lilian M. Cristofani, Vicente Odone-Filho, Lucia M. A. Campos, Adriana M. E. Sallum, Magda Carneiro-Sampaio, Artur F. Delgado, Werther B. Carvalho, Thais Mauad, Clovis A. Silva

Summary: This study aimed to evaluate the inconsistency between clinical diagnosis of death and autopsy findings in adolescents with chronic diseases. The results showed that there were major discrepancies between clinical diagnosis of death and autopsy findings in 30% of adolescents with chronic diseases. Pneumonia, pulmonary abscess, as well as isolation of yeast and virus were more frequently identified at autopsy findings in the groups with major discrepancies.

CLINICS (2023)

Meeting Abstract Rheumatology

ASYMPTOMATIC SARS-COV-2 INFECTION IN PEDIATRIC PATIENTS WITH JUVENILE DERMATOMYOSITIS AND OTHER RHEUMATIC DISEASES OF ONE TERTIARY REFERRAL HOSPITAL

Juliana R. Simon, Adriana M. Elias, Maria F. B. Pereira, Heloisa H. Marques, Bianca P. Ihara, Claudia A. A. Strabelli, Reinan T. Campos, Katia T. Kozu, Nadia E. Aikawa, Neusa K. Sakita, Sandra J. F. E. Grisi, Ana Paula S. Ferrer, Vera A. Santos, Vera Bain, Clovis A. Silva, Lucia M. A. Campos

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Meeting Abstract Rheumatology

NUTRITIONAL ASSESSMENT, BODY COMPOSITION AND PHASE ANGLE IN JUVENILE DERMATOMYOSITIS PATIENTS

Camila Pugliese, Katia T. Kozu, Lucia M. A. Campos, Nadia E. Aikawa, Clovis A. A. Silva, Adriana M. Elias

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Article Immunology

Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases

Luis Eduardo C. Andrade, Jan Damoiseaux, Diego Vergani, Marvin J. Fritzler

Summary: The classification and diagnosis of systemic autoimmune diseases rely on a set of criteria that include clinical, laboratory, imaging, and pathology factors. Autoantibodies play a crucial role in the classification criteria of many autoimmune diseases. HEp-2 indirect immunofluorescence assay is capable of detecting a wide range of autoantibodies. A positive HEp-2 IFA test can indicate the most likely autoantibody specificities in the sample. This paper suggests that the classification and diagnostic criteria for certain autoimmune diseases could be improved by modifying the accepted staining patterns for each disease based on relevant autoantibody specificities.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2022)

Article Rheumatology

Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis

Natalia Regine de Franca, Henri Andre Menard, Maximilien Lora, Zhijie Zhou, Joyce Rauch, Carol Hitchon, Luis Eduardo Coelho Andrade, Ines Colmegna

Summary: In this study, ECV304 cells were found to have self-citrullination capacity and novel cit-target proteins were identified in the autocitrullinated products immunoprecipitated by sera from RA patients. The auto-cit-prot-ECV304 ELISA showed high sensitivity and specificity for RA diagnosis.

ARTHRITIS RESEARCH & THERAPY (2022)

No Data Available